Tag: NASDAQ:GILD

Earnings Analysis of: Gilead Sciences Inc. (NASDAQ:GILD)

Gilead Sciences Inc. (NASDAQ:GILD) will report its next earnings on Apr 26 - May 1 (Est.). The company reported the earnings of $2.7/Share in...

Analysts showing optimistic trends for: Gilead Sciences Inc. (NASDAQ:GILD)

Gilead Sciences Inc. (NASDAQ:GILD) will report its next earnings on Apr 26 - May 1 (Est.). The company reported the earnings of $2.7/Share in...

Worth Watching Stock: Gilead Sciences Inc. (NASDAQ:GILD)

Gilead Sciences Inc. (NASDAQ:GILD) will report its next earnings on Apr 26 - May 1 (Est.). The company reported the earnings of $2.7/Share in...

What do Analysts Say about: Gilead Sciences Inc. (NASDAQ:GILD)

Gilead Sciences Inc. (NASDAQ:GILD) will report its next earnings on Apr 26 - May 1 (Est.). The company reported the earnings of $2.7/Share in...

Worth Watching Stock: Gilead Sciences Inc. (NASDAQ:GILD)

Gilead Sciences Inc. (NASDAQ:GILD) will report its next earnings on Apr 26 - May 1 (Est.). The company reported the earnings of $2.7/Share in...

Revenue Estimates Analysis: Gilead Sciences Inc. (NASDAQ:GILD)

Gilead Sciences Inc. (NASDAQ:GILD) will report its next earnings on Apr 26 - May 1 (Est.). The company reported the earnings of $2.7/Share in...

Price Target Analysis: Gilead Sciences Inc. (NASDAQ:GILD)

Gilead Sciences Inc. (NASDAQ:GILD) will report its next earnings on Apr 26 - May 1 (Est.). The company reported the earnings of $2.7/Share in...

Stock’s Earning Overview: Gilead Sciences Inc. (NASDAQ:GILD)

Gilead Sciences Inc. (NASDAQ:GILD) will report its next earnings on Apr 26 - May 1 (Est.). The company reported the earnings of $2.7/Share in...

Stock’s Earning Overview: Gilead Sciences Inc. (NASDAQ:GILD)

Gilead Sciences Inc. (NASDAQ:GILD) reported the earnings of $2.7/Share in the last quarter where the estimated EPS by analysts was $2.61/share. The difference between...

what are Analysts report about: Gilead Sciences Inc. (NASDAQ:GILD)

Gilead Sciences Inc. (NASDAQ:GILD) reported the earnings of $2.7/Share in the last quarter where the estimated EPS by analysts was $2.61/share. The difference between...